Poseida Therapeutics

Poseida Therapeutics

Poseida Therapeutics

Poseida Therapeutics is translating bestinclass gene editing technologies into lifesaving treatments and developing CAR Tcell immunotherapies for cancer
Suggest edits
Raised
$172.5M
Follow us
Also headquartered in San Diego
Companies in the same industry
Alexa global traffic share
Twitter followers
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 2

Add info
Add round
22 Apr 2019
$142,000,000
Venture capital (Series C)
Aisling Capital, Novartis, Perceptive Advisors, +6
04 Apr 2018
$30,500,000
Venture capital (Series B)
Longitude Capital, Vivo Capital, Tavistock Group, +1

Poseida Therapeutics snags $30.5 mln Series B

PE HUB
+2